Login

TI Ref No :	517054301
Description :	Open House Drug Discount Agreements For The Active Ingredient Natalizumab, Iv Dosage Form, Atc L04ag03, 67304 Eisenberg, Rhineland-palatinate
Date :	2025-04-19
Deadline :	2025-10-15
Document Type :	Tenders